Three former FDA chiefs criticized the DOGE cuts to the agency, saying they robbed the FDA of institutional knowledge that ...
White House planned shift of research funding from universities to industry risks creating a drought in basic research, ...
Lobbying groups for doctors and hospitals and trade groups are working behind the scenes on how to regulate AI in medicine.
Helen Branswell, STAT's infectious disease reporter who earned the respect of experts and public health officials with her ...
Whoop's chief medical officer, said the company's work with Medicare is an opportunity to prove its ability to improve health ...
The FTC asked a U.S. court to hold Martin Shkreli in contempt for “flagrantly” violating a court order banning him from ...
A wave of clinical trials have begun to test the ability of GLP-1 weight loss drugs to quell various substance use disorders, ...
Trump administration delays new rule that could restrict imported medicines from Canada and overseas
The Trump administration is delaying by 90 days a federal rule that could prevent Americans from obtaining prescription drugs ...
The legal and medical issues in the Christa Pike case are on a collision course,” writes bioethicist M. Sara Rosenthal.
Humana is swapping out private equity sponsors for its CenterWell Senior Primary Care clinics. Good bye, Welsh, Carson, ...
Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...
Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results